National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 64092 [2019-25116]
Download as PDF
<![CDATA[
64092
Federal Register / Vol. 84, No. 224 / Wednesday, November 20, 2019 / Notices
Federal Claims No: 19–1639V
89. Denise Bengston, Wichita, Kansas, Court
of Federal Claims No: 19–1643V
90. Shannon Cobb, Blue Springs, Missouri,
Court of Federal Claims No: 19–1645V
91. Robert Labianco, Virginia Beach, Virginia,
Court of Federal Claims No: 19–1646V
92. Tara Hunley, Madera, California, Court of
Federal Claims No: 19–1647V
93. Jessica Sandner, Portland, Oregon, Court
of Federal Claims No: 19–1648V
94. Teresa Buchanan, Chattanooga,
Tennessee, Court of Federal Claims No:
19–1649V
95. Lisa C. Salzer, Salisbury, North Carolina,
Court of Federal Claims No: 19–1650V
96. Robert R. Jodoin, Manchester, New
Hampshire, Court of Federal Claims No:
19–1651V
97. Janice Byrd, Boston, Massachusetts, Court
of Federal Claims No: 19–1655V
98. Janna Glassberg, Boston, Massachusetts,
Court of Federal Claims No: 19–1656V
99. Charisse Guasto, Tomah, Wisconsin,
Court of Federal Claims No: 19–1658V
100. Jordan Briggs, Richardson, Texas, Court
of Federal Claims No: 19–1659V
101. Robert Mele, Washington, Pennsylvania,
Court of Federal Claims No: 19–1660V
102. Kimberly Martin, Dallas, Texas, Court of
Federal Claims No: 19–1661V
103. Richard Rebeles, Chicago, Illinois, Court
of Federal Claims No: 19–1662V
104. Casey Wilson on behalf of C. W., Reno,
Nevada, Court of Federal Claims No: 19–
1663V
105. Kevin Carasiti, Wading River, New York,
Court of Federal Claims No: 19–1664V
106. Jennifer Cortez, San Diego, California,
Court of Federal Claims No: 19–1669V
107. Ashley Wirges, Washington, District of
Columbia, Court of Federal Claims No:
19–1670V
108. Valerie K. Hester on behalf of The Estate
of Marion Hester, Deceased, Durham,
North Carolina, Court of Federal Claims
No: 19–1671V
109. Susan Fitzgerald, Washington, District
of Columbia, Court of Federal Claims No:
19–1673V
110. David Griswold, Mission Hills,
California, Court of Federal Claims No:
19–1674V
111. George Girard Hammer, Jeffersontown,
Kentucky, Court of Federal Claims No:
19–1675V
112. Gerald Lengkeek, Holland, Michigan,
Court of Federal Claims No: 19–1678V
113. Traci Jones, Redlands, California, Court
of Federal Claims No: 19–1680V
114. MaryGrace Fagen, Schererville, Indiana,
Court of Federal Claims No: 19–1681V
115. Kim Reed, Winfield, Alabama, Court of
Federal Claims No: 19–1682V
116. Hanna Reynolds, Davie, Florida, Court
of Federal Claims No: 19–1683V
117. Frank Coluccio, Beverly Hills,
California, Court of Federal Claims No:
19–1684V
118. Sharon Stephens, Victorville, California,
Court of Federal Claims No: 19–1685V
119. Trevor Miller, Allentown, Pennsylvania,
Court of Federal Claims No: 19–1686V
120. Lindsay Carlson, Modena, New York,
Court of Federal Claims No: 19–1687V
121. Kristin Ivanovski, Hackensack, New
VerDate Sep<11>2014
17:21 Nov 19, 2019
Jkt 250001
Jersey, Court of Federal Claims No: 19–
1690V
122. Emily Hirst, Gainesville, Georgia, Court
of Federal Claims No: 19–1691V
123. Kristi Napier, New Albany, Indiana,
Court of Federal Claims No: 19–1692V
124. Raven Tubbs, Dallas, Texas, Court of
Federal Claims No: 19–1693V
125. Jennifer Kohlmeyer, Englewood, New
Jersey, Court of Federal Claims No: 19–
1694V
126. Kathy J. Stopar, Racine, Wisconsin,
Court of Federal Claims No: 19–1695V
127. Nidal Zaidan, Dresher, Pennsylvania,
Court of Federal Claims No: 19–1697V
128. Lindsay Ward, Dresher, Pennsylvania,
Court of Federal Claims No: 19–1698V
129. Mir Hassan, Bloomingdale, Illinois,
Court of Federal Claims No: 19–1699V
[FR Doc. 2019–25099 Filed 11–19–19; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; HIV/AIDS Clinical Trials
Networks Statistical and Data Management
Centers (UM1 Clinical Trial Required).
Date: December 12–13, 2019.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Cambria Hotel Rockville, 1 Helen
Heneghan Way, Rockville, MD 20850.
Contact Person: Cynthia Louise De La
Fuente, Ph.D., Scientific Review Officer,
Scientific Review Program, Division of
Extramural Activities, National Institutes of
Health, NIAID, 5601 Fishers Lane, MSC–
9823, Rockville, MD 20852, 240–669–2740,
delafuentecl@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
Dated: November 14, 2019.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–25116 Filed 11–19–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID SBIR Phase II
Clinical Trial Implementation Cooperative
Agreement (U44 Clinical Trial Required).
Date: December 16, 2019.
Time: 9:00 a.m. to 11:00 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Kelly Lorraine Hudspeth,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institutes of Health, NIAID, 5601
Fishers Lane, MSC–9823 Rockville, MD
20852, 240–669–5067, kelly.hudspeth@
nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Collaborative Cross Mouse
Model Generation and Discovery of
Immunoregulatory Mechanisms (R21).
Date: January 8–9, 2020.
Time: 9:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Margaret Allison Morris
Fears, Ph.D., Scientific Review Officer,
Scientific Review Program, Division of
Extramural Activities, National Institutes of
Health, NIAID, 5601 Fishers Lane, MSC–
9823, Rockville, MD 20852,
maggie.morrisfears@nih.gov.
E:\FR\FM\20NON1.SGM
20NON1
]]>Agencies
[Federal Register Volume 84, Number 224 (Wednesday, November 20, 2019)]
[Notices]
[Page 64092]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-25116]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; HIV/AIDS Clinical Trials Networks
Statistical and Data Management Centers (UM1 Clinical Trial
Required).
Date: December 12-13, 2019.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Cambria Hotel Rockville, 1 Helen Heneghan Way, Rockville,
MD 20850.
Contact Person: Cynthia Louise De La Fuente, Ph.D., Scientific
Review Officer, Scientific Review Program, Division of Extramural
Activities, National Institutes of Health, NIAID, 5601 Fishers Lane,
MSC-9823, Rockville, MD 20852, 240-669-2740,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: November 14, 2019.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-25116 Filed 11-19-19; 8:45 am]
BILLING CODE 4140-01-P
